📸 Helena Cornu
📸 Helena Cornu
Develop a comprehensive open source side effect resource and standardised AI/ML training sets to improve early identification of safety liabilities
Apply by 11 January
embl.wd103.myworkdayjobs.com/en-US/EMBL/j...
Develop a comprehensive open source side effect resource and standardised AI/ML training sets to improve early identification of safety liabilities
Apply by 11 January
embl.wd103.myworkdayjobs.com/en-US/EMBL/j...
Thanks to a GWAS Catalog update including 3 major studies using UK Biobank data, we now have over 1.4 million GWAS credible sets in the Platform.
Discover the data, feature, and technical updates in this release: blog.opentargets.org/open-targets... 🧬🖥️
Thanks to a GWAS Catalog update including 3 major studies using UK Biobank data, we now have over 1.4 million GWAS credible sets in the Platform.
Discover the data, feature, and technical updates in this release: blog.opentargets.org/open-targets... 🧬🖥️
There are many research focus areas available, including Open Targets translational AI projects
Apply now: sanger.wd103.myworkdayjobs.com/en-US/Wellco...
There are many research focus areas available, including Open Targets translational AI projects
Apply now: sanger.wd103.myworkdayjobs.com/en-US/Wellco...
Perform large-scale phenotypic CRISPR screens on human iPSC-derived microglia to identify modifiers of immune dysfunction relating to neurodegeneration 🧬
Apply by 11 January: sanger.wd103.myworkdayjobs.com/en-US/Wellco...
#ScienceJobs
Perform large-scale phenotypic CRISPR screens on human iPSC-derived microglia to identify modifiers of immune dysfunction relating to neurodegeneration 🧬
Apply by 11 January: sanger.wd103.myworkdayjobs.com/en-US/Wellco...
#ScienceJobs
Meet Lit-OTAR, a deep learning framework built by Europe PMC and @opentargets.org
It’s identified >48.5 million unique associations, accelerating the drug discovery process!
Read the thread for a paper summary👇
#AI4Science #BioNLP #DrugDiscovery
Meet Lit-OTAR, a deep learning framework built by Europe PMC and @opentargets.org
It’s identified >48.5 million unique associations, accelerating the drug discovery process!
Read the thread for a paper summary👇
#AI4Science #BioNLP #DrugDiscovery
Benchmark and integrate state-of-the-art network contextualisation methods, combining large-scale transcriptomics, proteomics, and single-cell data
Apply by 17 Dec
embl.wd103.myworkdayjobs.com/en-US/EMBL/j...
Benchmark and integrate state-of-the-art network contextualisation methods, combining large-scale transcriptomics, proteomics, and single-cell data
Apply by 17 Dec
embl.wd103.myworkdayjobs.com/en-US/EMBL/j...
Findings from this project will be integrated into the Open Targets Platform to help identify and prioritise the most promising therapeutic targets.
Findings from this project will be integrated into the Open Targets Platform to help identify and prioritise the most promising therapeutic targets.
The Open Psychiatry Project aims to change that with a secure platform linking genetic and clinical mental health data.
@cam.ac.uk @opentargets.org
www.ebi.ac.uk/about/news/a...
The Open Psychiatry Project aims to change that with a secure platform linking genetic and clinical mental health data.
@cam.ac.uk @opentargets.org
www.ebi.ac.uk/about/news/a...
Thank you to everyone who joined in person and online, and who contributed to make this event a success
Particular thanks to our sponsors: Gates Foundation, Google Cloud, and @thehyvenl.bsky.social 🎉
Thank you to everyone who joined in person and online, and who contributed to make this event a success
Particular thanks to our sponsors: Gates Foundation, Google Cloud, and @thehyvenl.bsky.social 🎉
Following our official kick off yesterday, there was some incredible energy and focus in the room
Thanks to our sponsors Gates Foundation, Google Cloud, and @thehyvenl.bsky.social for making this possible!
Following our official kick off yesterday, there was some incredible energy and focus in the room
Thanks to our sponsors Gates Foundation, Google Cloud, and @thehyvenl.bsky.social for making this possible!
We're super excited to kick off this event celebrating 10 years of the Open Targets Platform
Thank you to Google Cloud for sponsoring our compute and Hariprasad Radhakrishnan for mentoring our teams and sharing this video — made with Google Veo 3! 🖥️🧬
We're super excited to kick off this event celebrating 10 years of the Open Targets Platform
Thank you to Google Cloud for sponsoring our compute and Hariprasad Radhakrishnan for mentoring our teams and sharing this video — made with Google Veo 3! 🖥️🧬
Go find Daniel at poster board 1014T!
Go find Daniel at poster board 1014T!
Apply through LinkedIn by 5 October: www.linkedin.com/jobs/view/43...
#scienceJobs #AcademicSky #postdocJobs
Apply through LinkedIn by 5 October: www.linkedin.com/jobs/view/43...
#scienceJobs #AcademicSky #postdocJobs
An Open Targets team led by Krista Freimann and @kauralasoo.bsky.social analysed 3,734 lymphoblastoid cell line samples across nine cohorts, identifying four robust loci
www.nature.com/articles/s41...
An Open Targets team led by Krista Freimann and @kauralasoo.bsky.social analysed 3,734 lymphoblastoid cell line samples across nine cohorts, identifying four robust loci
www.nature.com/articles/s41...
➡️ Senior Bioinformatician with Roser Vento Tormo
sanger.wd103.myworkdayjobs.com/en-US/Wellco...
➡️ Technical Specialist (neuro) with Omer Ali Bayraktar
sanger.wd103.myworkdayjobs.com/en-US/Wellco...
Both @sangerinstitute.bsky.social roles close on 2 October
➡️ Senior Bioinformatician with Roser Vento Tormo
sanger.wd103.myworkdayjobs.com/en-US/Wellco...
➡️ Technical Specialist (neuro) with Omer Ali Bayraktar
sanger.wd103.myworkdayjobs.com/en-US/Wellco...
Both @sangerinstitute.bsky.social roles close on 2 October
The E2G Portal! e2g.stanford.edu
This collates our predictions of enhancer-gene regulatory interactions across >1,600 cell types and tissues.
Uses cases 👇
1/
The E2G Portal! e2g.stanford.edu
This collates our predictions of enhancer-gene regulatory interactions across >1,600 cell types and tissues.
Uses cases 👇
1/
We have ingested the full dataset of over 13 million enhancer-gene regulatory interactions in the human genome across 1,458 DNase-seq experiments covering 369 cell types and tissues from the ENCODE-rE2G model
blog.opentargets.org/open-targets...
We have ingested the full dataset of over 13 million enhancer-gene regulatory interactions in the human genome across 1,458 DNase-seq experiments covering 369 cell types and tissues from the ENCODE-rE2G model
blog.opentargets.org/open-targets...
Launched in 2008, took us 15 years to reach 500K, and thanks to your research and collaboration, we doubled the number in less than 3 years!
See some data insights tinyurl.com/mw53njbb
#OpenAccess
Launched in 2008, took us 15 years to reach 500K, and thanks to your research and collaboration, we doubled the number in less than 3 years!
See some data insights tinyurl.com/mw53njbb
#OpenAccess
Submit a project by 12 September: docs.google.com/forms/d/e/1F...
We will prioritise projects where the project leads have signed up to attend the hackathon. Registrations are currently full but you can sign up to the waiting list
Submit a project by 12 September: docs.google.com/forms/d/e/1F...
We will prioritise projects where the project leads have signed up to attend the hackathon. Registrations are currently full but you can sign up to the waiting list
A team from the Cowley, Bassett, and @gosiatrynka.bsky.social labs integrate pooled iPSC phenotyping, transcriptomics, and CRISPR perturbations to identify genetic drivers of molecular and cellular phenotypes in microglia
www.biorxiv.org/content/10.1...
#neuroskyence
A team from the Cowley, Bassett, and @gosiatrynka.bsky.social labs integrate pooled iPSC phenotyping, transcriptomics, and CRISPR perturbations to identify genetic drivers of molecular and cellular phenotypes in microglia
www.biorxiv.org/content/10.1...
#neuroskyence
Lewis Evans and the team at @sangerinstitute.bsky.social and UCL define the pathways for tau entry into human neurons, a key mechanism for the progression of tauopathies associated with Parkinson’s and Alzheimer’s disease
www.embopress.org/doi/full/10....
#neuroscience #neuroskyence
Lewis Evans and the team at @sangerinstitute.bsky.social and UCL define the pathways for tau entry into human neurons, a key mechanism for the progression of tauopathies associated with Parkinson’s and Alzheimer’s disease
www.embopress.org/doi/full/10....
#neuroscience #neuroskyence